Senator Burr criticizes government sitting prescription drug prices

North Carolina Senator Richard Burr says at Senate HELP Committee nomination hearing with Xavier Becerra nominated to be HHS Secretary that his actions as Attorney General of California and tenure in Congress revealed a disregard for the value of healthcare ingenuity, calling for policies that would undo decades of investment in support of biomedical research, incentives to innovate always the linchpin to bring up to American patients including countermeasures for coronavirus platform technologies and rare diseases in breakthroughs like the devastating effects of all the present dementia, demanding Manufacturers Hanover protections for their innovations and discourage the development of transfer life threatening diseases should be cause for concern, a 1980 act was very prescribed in criteria for marching rights and even sponsors Birch Bayh and Bob Dole said they never intended government to set prices or intentionally omit referencing pricing in the long run.